[Federal Register Volume 64, Number 129 (Wednesday, July 7, 1999)]
[Notices]
[Page 36717]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-17096]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Application

    Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on April 27, 1999, Damocles10, 
3529 Lincoln Highway, Thorndale, Pennsylvania 19372, made application 
by renewal to the Drug Enforcement Administration (DEA) for 
registration as a bulk manufacturer of the basic classes of controlled 
substances listed below:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Codeine-N-oxide (9053).....................  I
Heroin (9200)..............................  I
Morphine-N-oxide (9307)....................  I
Amphetamine (1100).........................  II
Methamphetamine (1105).....................  II
Phencyclidine (7471).......................  II
Codeine (9050).............................  II
Morphine (9300)............................  II
------------------------------------------------------------------------

    The firm plans to manufacture the listed controlled substances for 
the purpose of deuterium labeled internal standards for distribution to 
analytical laboratories.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substances may file comments or objections 
to the issuance of the proposed registration.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, DC 20537, Attention: DEA Federal Register Representative 
(CCR), and must be filed no later than September 7, 1999.

    Dated: June 23, 1999.
John H. King,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 99-17096 Filed 7-6-99; 8:45 am]
BILLING CODE 4410-09-M